Abivax Announces Full Year 2024 Financial Results
Abivax Announces Full Year 2024 Financial Results • Cash balance of EUR 144.2M as of December 31, 2024; cash runway into […]
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results…
Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application […]
LEADING EDGE MATERIALS’ NORRA KARR HREE PROJECT MOVES FORWARD
LEADING EDGE MATERIALS’ NORRA KÄRR HREE PROJECT MOVES FORWARD Vancouver, March 23, 2025 – Leading Edge Materials Corp. (“Leading Edge Materials” […]
SEALSQ, a WISeKey Affiliate, and WeCanGroup Sign Strategic Agreement for SEALSQ to Acquire a 30% Stake in WeCanGroup
Geneva, Switzerland, March 24, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”),a subsidiary of WISeKey, and WeCanGroup […]
Opthea Announces COAST Phase 3 Trial Topline Results
COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from baseline to week 52 Opthea […]
